Chronic Disease
-
Antivirals may benefit some inpatients
Elevated virus levels in hospitalized COVID-19 patients’ blood predicts worsening respiratory symptoms and suggests ongoing viral replication in later disease stages, Stanford Medicine-led study says.
-
Possible treatment for mucus-induced lung diseases
Stanford Medicine investigators and their collaborators have designed a compound that’s uniquely capable of blocking excessive mucus secretion — a hallmark of several serious respiratory disorders.
-
Ami Bhatt on gut microbiomes
The Stanford Medicine professor on why it’s important to better understand the microbiome of people transitioning from traditional to Westernized lifestyles.
-
COVID-19 hospitalizations among kids likely overcounted
Children being treated in hospitals are tested for SARS-CoV-2, but many who test positive never develop COVID-19 symptoms, leading to overestimates of disease severity, a study found.
-
Study of COVID-19 saliva test
An at-home COVID-19 test, designed by Stanford researchers to be easy to use and provide results within 30 minutes, will be the focus of a study funded by the Stanford Medicine Catalyst Program.
-
Biomarker for lipedema discovered
Researchers have identified a molecule that ties lipedema to other lymphatic diseases, such as lymphedema, and distinguishes it from obesity.
-
New center for rare eye disease
A $10 million gift has enabled the launch of a center focusing on optic disc drusen, a poorly understood eye disease that can lead to visual impairment or even blindness.
-
Microbial loss, ulcerative colitis linked
Bacteria normally inhabiting healthy people’s intestines — and the anti-inflammatory metabolites these bacteria produce — are depleted in ulcerative colitis patients, a Stanford study shows.
-
Stanford-led teams nab top clinical research prizes
Winning studies were chosen by members of the Clinical Research Forum, a nonprofit foundation that promotes the understanding of clinical research and its impact on health and health care.
-
Inflammation turns mutation deadly
A simple viral infection in the lungs of rats can become a lethal form of pulmonary hypertension if a common mutation is present, new Stanford research shows.
-
Possible ‘bubble boy’ disease therapy
In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.
- Administration
- Aging
- Big Data
- Biochemistry
- Bioengineering
- Cancer
- Cardiovascular Health
- Chemical Biology
- Chronic Disease
- COVID-19
- Developmental Biology
- Education
- Genetics
- Global Health
- Health Policy
- Hearing
- Imaging
- Immunology
- Infectious Disease
- Mental Health
- Neuroscience
- Nutrition
- Obituaries
- Pain
- Patient Care
- Pediatrics
- Precision Health
- Preventive Medicine
- Sleep
- Stem Cells
- Surgery
- Technology
- Transplantation
- Urology
- Women's Health